Covid-19 roundup: Ex­perts wor­ry mol­nupi­ravir de­mand will leave poor coun­tries be­hind as Mer­ck says it will dou­ble pro­duc­tion

As Mer­ck’s high­ly an­tic­i­pat­ed Covid-19 an­tivi­ral pill awaits emer­gency use au­tho­riza­tion from the FDA, coun­tries are lin­ing up for sup­ply con­tracts, which like­ly could leave …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER